Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Here, we study the intricate relationship between gut microbiota and host cometabolic phenotypes associated with dietary-induced impaired glucose homeostasis and nonalcoholic fatty liver disease (NAFLD) in a mouse strain (129S6) known to be susceptible to these disease traits, using plasma and urine metabotyping, achieved by (1)H NMR spectroscopy. Multivariate statistical modeling of the spectra shows that the genetic predisposition of the 129S6 mouse to impaired glucose homeostasis and NAFLD is associated with disruptions of choline metabolism, i.e., low circulating levels of plasma phosphatidylcholine and high urinary excretion of methylamines (dimethylamine, trimethylamine, and trimethylamine-N-oxide), coprocessed by symbiotic gut microbiota and mammalian enzyme systems. Conversion of choline into methylamines by microbiota in strain 129S6 on a high-fat diet reduces the bioavailability of choline and mimics the effect of choline-deficient diets, causing NAFLD. These data also indicate that gut microbiota may play an active role in the development of insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A causal role for the involvement of gut microbes is in part based on the fulfillment of one of Koch’s postulates - namely, the transmission of a disease related phenotype with transplantation of gut microbial organisms to a new host (Cho and Blaser, 2012; Cox et al., 2014; Dumas et al., 2006; Gregory et al., 2015; Koch, 1880; Sandhu and Chase, 1986).”
From Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis (2015) · cites this paper as Dumas et al., 2006
In the citing paper
“Interestingly, dysbiotic microbiota from mice fed a high-fat diet metabolize and convert dietary choline into methylamines, resulting in low circulating levels of plasma phosphatidylcholine60.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [60]
In the citing paper
“Serum and urinary concentrations of methylamines including TMAO were associated with the development of nonalcoholic fatty liver and impairment of glucose metabolism in high-fat-fed 129S6 mice (39).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [39]
In the citing paper
“It has been demonstrated that the gut microbiota can play a role in the development of metabolic abnormalities such as insulin resistance and nonalcoholic fatty liver disease76,77.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [77]
Citations
Cites
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Self-citationMetabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
Self-citation
Research works printed but not linked: 2
- A. L. Buchman, M. D. Dubin, A. A. Moukarzel, D. J. Jenden, M. Roch, K. M. Rice, J. Gornbein, M. E. Ament Hepatology 22, 1399–1403 (1995).
- S. H. Zeisel, J. S. Wishnok, J. K. Blusztajn J. Pharmacol. Exp. Ther. 225, 320–324 (1983).
Cited by
Items 901–942 of 942
Swierczek, D., Dreger, M., Jatkowski, J., Kancerek, J., Drozdzowska, B., & Wojnicz, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177825
“A FIB-4 value 1.30 provides a high negative predictive value, effectively identifying low-risk patients who do not require further specialist evaluation [4,5], whereas a value > 2.67 indicates a high risk of advanced fibrosis and warrants further diagnostic assessment [35].”
InfluentialLiu, J., Zhao, M., Wang, S., Zhang, C., Zhong, Y., & Qu, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1917467
“…exhibited reduced plasma phosphatidylcholine together with increased urinary dimethylamine, trimethylamine (TMA), and trimethylamine N-oxide (TMAO), linking high-fat diet-induced fatty liver in this strain to microbial methylamine production and reduced host-accessible choline (Dumas et al., 2006).”
Exploring Endotoxemia in Age-Related Macular Degeneration, Glaucoma, and Diabetic Retinopathy
Larsen, P. P., Linard, M., Schweitzer, C., Delyfer, M., Korobelnik, J., Helmer, C., & Delcourt, C. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.10.14
New Functional Fermented Mare’s Milk Product: Biological Assessment in vivo
Симоненко, Е. С., Симоненко, С. В., Бегунова, А. В., Петров, А. Н., & Semenova, E. (2024) · Food Processing Techniques and Technology · doi:10.21603/2074-9414-2024-4-2535
Quality Attributes of Four Kale Cultivars Grown in a High Tunnel Ecological Farming System
Tamas, V., Apahidean, A., Chiorean, C., Rózsa, S., Gocan, T., Sima, R., & Măniuţiu, D. (2024) · Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca: Horticulture · doi:10.15835/buasvmcn-hort:2023.0032
MECHANISMS OF ATHEROGENESIS AND ITS INTENSIFICATION IN PATIENTS WITH RHEUMATOID ARTHRITIS
Кazymyrko, V. К., Іvanitska, L. N., Silantieva, Т. S., Dubkova, А. G., & Kutovоy, V. V. (2020) · Likarska sprava · doi:10.31640/jvd.7-8.2020(2
The Role of Gut Microbiome-Targeted Therapy in Nonalcoholic Fatty Liver Disease
Xie, C., & Halegoua-DeMarzio, D. L. (2020) · Current Hepatology Reports · doi:10.1007/s11901-020-00547-5
Advances on Research in Protein-Enriched Cow’s Milk: A Review from Omics Perspective
Conejos, J. R., & Lee, H.-G. (2018) · doi:10.20944/preprints201810.0411.v1
“These approaches have already been applied in ruminant nutrition to determine correlations of different nutritional management with metabolic profiling of milk, rumen epithelial tissue, ruminal fluid, gut contents, blood plasma and urine [108,109,110].”
BackgroundGut Flora in the Development and Progression of Nonalcoholic Fatty Liver Disease
Okwu, V., & Matloob, A. (2015) · Journal of Liver Disease & Transplantation · doi:10.4172/2325-9612.1000128
“In one study, when the 129S6 mouse was fed a high fat-diet, the increased microbial enzyme activity led to decreased bioavailability of choline, with resultant symptoms that mimicked NAFLD caused by a choline-deficient diet [72].”
BackgroundBrandl, K., & Schnabl, B. (2016) · Wiley eBooks · doi:10.1002/9781118982907.ch22
Gut Microbiome and Functional Foods
Kumar, A., Singh, S., & Chauhan, A. K. (2015) · Wiley eBooks · doi:10.1002/9781118930458.ch38
Rahman, S. A. (2015) · doi:10.14264/uql.2015.734
“Higher levels of plasma choline and TMAO have been associated with the development of CVD in both human and mice studies (Dumas et al., 2006, Wang et al., 2011).”
BackgroundIII. NASH/NAFLD and Gut Microbiota
Tomita, K., & Hokari, R. (2015) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.104.48
Non-alcoholic fatty liver disease in patients with diabetes mellitus
Naini, S. R., & Fuchs, M. A. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.938053
“Finally, microbiota convert dietary choline into toxic methylamines [52], thereby reducing circulating plasma levels of phosphatidylcholine to generate a choline-deficient state [53].”
BackgroundProbiotics and Prebiotics in Obesity and Energy Metabolism
Erbağcı, A. B. (2013) · CRC Press eBooks · doi:10.1201/b15561-12 · Cited by 1
Rôle du Liver X Receptor dans la régulation transcriptionnelle de la lipogenèse
Ducheix, S. (2013) · theses.fr (ABES) · doi:10.70675/59bbf155z0d40z4bcazad98z24045b25a54f
Narahara, H., Sakai, E., Katayama, M., Ohtomo, Y., Yamamoto, K., Takemoto, M., Aso, H., Ohwada, S., Mohri, Y., Nishimori, K., et al. (2012) · Animal science journal = Nihon chikusan Gakkaiho · doi:10.1111/j.1740-0929.2011.00980.x
Human Intestinal Microbiome: Etiology of Inflammation Genomics
Clemens, R. (2011) · CRC Press eBooks · doi:10.1201/b11294-22
Systems Biology of Host–Food–Microbe Interactions in the Mammalian Gut
dos Santos, V. A. P. M., Müller, M. M., de Vos, W. M., Wells, J. M., PAS, M. F. W. T., Hooiveld, G. J. E. J., van Baarlen, P., Smits, M. A., & Keijer, J. (2011) · Wiley eBooks · doi:10.1002/9780470963012.ch5 · Cited by 1
New metabolic markers of heart disease
Fulmer, T. (2011) · doi:10.1038/scibx.2011.447
Metabolic Profiling for Biomarker Discovery
Keun, H. C. (2010) · Wiley eBooks · doi:10.1002/9780470918562.ch4
Comprehensive Metabolic Analysis for Understanding of Disease Mechanisms
Newgard, C. B., Stevens, R. D., Wenner, B. R., Burgess, S. C., Ilkayeva, O., Muehlbauer, M. J., Sherry, A. D., & Bain, J. R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369420-1.00015-9
Lectures and Oral Presentations
Kerhoas, N., Chesneau, G., Legrand, P., Frigerio, F., Carobbio, S., Kohler, I., Mlynárik, V., Gruetter, R., P., Maechler, et al. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00017.x
“Metabolic profiling reveals the effect of microbial metabolism in several aspects of insulin-resistance related pathologies(2,3,4) and provides independent validation of several metagenomic studies(5).”
BackgroundExploring the Link Between Gut Microbes and Obesity
Shanahan, F. (2007) · Future Microbiology · doi:10.2217/17460913.2.3.261
“The potential importance of this body of work is further highlighted by work from others using metabolic profiling to demonstrate a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice [11].”
McClain, C. J., Smart, L., Safadi, S., & Kirpich, I. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818460-8.00026-5 · Cited by 2
A Compromised Liver Alters PCB Toxicity and Nutrient Metabolism
Barney, J. (2019) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2019.370
“This consequently reduces the systemic plasma phosphatidylcholine levels, generating a phenotype similar to the NASH producing choline-deficient diets.([131]) Regardless, the use of other diet-induced liver injury mouse models, like the high fat diet (HFD), may be useful to compare and contrast the findings obtained i…”
ResultGut Microbiomes and Their Impact on Human Health
Mitra, R., Das, L. M., & Das, S. K. (2019) · Springer eBooks · doi:10.1007/978-981-13-8315-1_12 · Cited by 1
Gut Microbes in Liver Diseases
Arunima, A., Das, J. K., & Suar, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814468-8.00010-7 · Cited by 1
Polyphenols in the Management of Chronic Liver Diseases Including Hepatocellular Carcinoma
Shukla, S. K., & Kumar, V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814466-4.00006-9 · Cited by 2
Philips, C., & Bihari, C. (2016) · doi:10.5455/ijsm.helicobacter-pylory-infection
“pylori in causation and progression of metabolic diseases has been well described; and in light of it, the evidence for causality associated with non-alcoholic fatty liver disease (NAFLD) and gut microbiota dysbiosis with the importance to Helicobacter species can be gleaned [7, 8].”
BackgroundRobertson, C. L., Sarkar, D., & Sanyal, A. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-34214-6_18 · Cited by 1
Ketone Body Metabolism Preserves Hepatic Function during Adaptation to Birth and in Overnutrition
Cotter, D. (2015) · doi:10.7936/k7hq3x2b
“hypertension, insulin resistance, and atherosclerosis (210-213).”
Metabonomic Phenotyping for the Gut Microbiota and Mammal Interactions
Tang, H., & Wang, Y. (2014) · Advanced topics in science and technology in China · doi:10.1007/978-3-662-43883-1_8
A Nutritional Anthropology of the Human Gut Microbiota
Filippo, C. D., & Tuohy, K. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407825-3.00002-2 · Cited by 2
Probiotics and Prebiotics and the Gut Microbiota
Quigley, E. M. M. (2013) · CRC Press eBooks · doi:10.1201/b15561-13 · Cited by 5
Metagenomic Applications and the Potential for Understanding Chronic Liver Disease
Schnabl, B. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7089-3_13
“Conversion of choline into methylamines by microbiota in a susceptible mouse strain reduces the bioavailability of choline and mimics the effect of choline-deficient diets causing NAFLD (see below) ( Dumas et al., 2006 ).”
BackgroundSymbiotic Gut Microbiota and the Modulation of Human Metabolic Phenotypes
Li, L. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7089-3_14 · Cited by 1
Coulier, L., Wopereis, S., Rubingh, C. M., Hendriks, H., Radonjić, M., & Jellema, R. H. (2009) · Elsevier eBooks · doi:10.1016/b978-044452701-1.00014-4 · Cited by 4
Metadata
- Authors
- Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., Mitchell, S. C., Holmes, E., McCarthy, M. I., Scott, J., Gauguier, D., & Nicholson, J. K.
- Affiliations
- Imperial College London (GB)
- *Department of Biological Chemistry and
- Centre for Human Genetics (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-08-15
- Volume
- 103
- Issue
- 33
- Pages
- 12511-12516
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1567909
- OpenAlex
- W2139464173
- Cited by
- 1,042
- References
- 0
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 29 · 2023: 26 · 2022: 43 · 2021: 57 · 2020: 52 · 2019: 80 · 2018: 70 · 2017: 67 · 2016: 86 · 2015: 72 · 2014: 63 · 2013: 80 · 2012: 62
- FWCI
- 17.42
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (057733, 066786)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- gut microbiota, non-alcoholic fatty liver disease, insulin resistance, choline metabolism, phosphatidylcholine, trimethylamine N-oxide, methylamine, high-fat diet, impaired glucose homeostasis, metabotyping, host-microbe interactions, choline deficiency
- MeSH terms
- Animals, Body Weight, Dietary Fats, Fatty Liver, Glucose, Homeostasis, Insulin, Insulin Resistance, Lipids, Liver, Male, Methylamines, Mice, Inbred BALB C, Phenotype, Multivariate Analysis, Nuclear Magnetic Resonance, Biomolecular, Gastrointestinal Tract, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.